The first Hoth Therapeutics trade was made in Q2 2020.
Since then Jim Simons bought shares six more times and sold shares on six occasions. The investor completely sold their stake between Q4 2025 and Q1 2026.
Avg closing price
Price range
Sold -33.8k shares
Q1 2026
Avg closing price
$0.99
Price range
$0.77
-
$1.14
Sold 86.1% shares (-210k shares)
Q4 2025
Avg closing price
$1.27
Price range
$0.99
-
$1.67
New holding (+244k shares)
Q3 2025
Avg closing price
$1.41
Price range
$1.16
-
$2.07
Sold -5.44k shares
Q4 2022
Avg closing price
$5.29
Price range
$2.96
-
$10.72
Sold 13.5% shares (-847 shares)
Q3 2022
Avg closing price
$10.34
Price range
$8.70
-
$11.88
Increased shares by 77.9% (+2.75k shares)
Q2 2022
Avg closing price
$12.74
Price range
$9.50
-
$26.25
Sold 47.1% shares (-3.15k shares)
Q1 2022
Avg closing price
$16.73
Price range
$12.98
-
$32.50
New holding (+6.68k shares)
Q4 2021
Avg closing price
$23.67
Price range
$16.50
-
$29.50
Sold -8.84k shares
Q2 2021
Avg closing price
$39.11
Price range
$32.75
-
$53.50
Increased shares by 40.6% (+2.55k shares)
Q1 2021
Avg closing price
$56.03
Price range
$46.25
-
$76.00
Increased shares by 98.5% (+3.12k shares)
Q4 2020
Avg closing price
$44.11
Price range
$39.50
-
$59.25
Increased shares by 233.8% (+2.22k shares)
Q3 2020